這場病讓我有了重新選擇一種生活方式的契機 癌症是一場劫難 我們都在書寫自己的奇跡 生命以痛吻我 我卻報之以歌 學術論文 Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in ALK-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors：A Brief Report Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression 國際指南推薦的肺癌表皮生長因子受體基因突變和間變性 淋巴瘤激?基因重排檢測及其臨床進展 Long-term Survival Associated with Crizotinib in a Lung Cancer Patient with a Pulmonary Artery Embolism c-ROS癌基因1融合陽性肺腺癌54例臨床特徵分析 Detection of non-reciprocal/reciprocal ALK translocation as poor predictive marker in first-line crizotinib-treated ALK-rearranged non-small cell lung cancer patients Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib：a case report Investigation on the survival implications of PD-L1 expression status in ALK-rearranged advanced non-small cell lung cancer treated with first-line crizotinib Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer Loss of 5' ALK leads to better response to crizotinib in sarcomas with ALK rearrangement
[